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Abstract
Background:  Local  anesthetics  (LAs)  are  generally  considered  as  safe,  but  cytotoxicity  has  been
reported for  several  local  anesthetics  used  in  humans,  which  is  not  well  investigated.  In  the
present study,  the  cytotoxicity  of  lidocaine,  ropivacaine  and  the  combination  of  lidocaine  and
ropivacaine  were  evaluated  on  human  melanoma  cell  lines.  Melphalan,  a  nitrogen  mustard
alkylating agent,  was  used  as  a  control  agent  for  comparison  of  cytotoxic  activity.
Methods:  Melanoma  cell  lines,  A375  and  Hs294T,  were  exposed  to  1  h  to  different  concentrations
of above  agents.  Cell-viability  after  exposure  was  determined  by  ﬂow  cytometry.
Results:  Investigated  LAs  showed  detrimental  cytotoxicity  on  studied  melanoma  cell  lines  in
time- (p  <  0.001),  concentration-  (p  <  0.001),  and  agent  dependant.  In  both  A375  and  Hs294T
cell lines,  minimum  cell  viability  rates  were  found  after  72  h  of  exposure  to  these  agents.
Lidocaine 2%  caused  a  reduction  of  vital  cells  to  10%  ±  2%  and  14%  ±  2%  in  A375  and  Hs294T,
respectively  after  72  h  of  exposure.  Ropivacaine  0.75%  after  72  h  reduced  viable  cells  to  15%  ±  3%
and 25%  ±  3%  in  A375  and  Hs294T,  respectively.  Minimum  cell  viability  after  72  h  exposure  to  the
combination  was  10%  ±  2%  and  18%  ±  2%  in  A375  and  Hs294T,  respectively.  Minimum  cell  viability
after 72  h  exposure  to  melphalan  was  8%  ±  1%  and  12%  ±  2%,  in  A375  and  Hs294T,  respectively.
Conclusion:  LAs  have  cytotoxic  activity  on  human  melanoma  cell  lines  in  a  time-,  concentration-
and agent-dependant  manner.  Apoptosis  in  the  cell  lines  was  mediated  through  activity  of
caspases-3 and  caspases-8.
©  2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).∗ Corresponding author.
E-mail: kangdingkun63@gmail.com (D-K. Kang).
ttp://dx.doi.org/10.1016/j.bjane.2015.04.002
104-0014/© 2016 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Efeitos  citotóxicos  de  anestesia  local  com  lidocaína/ropivacaína  em  linhagens
celulares  de  melanoma  humano
Resumo
Justiﬁcativa:  Os  anestésicos  locais  (ALs)  são  geralmente  considerados  como  seguros,  mas  cito-
toxicidade foi  relatada  em  vários  anestésicos  locais  usados  em  seres  humanos,  a  qual  não  é  bem
investigada.  No  presente  estudo,  a  citotoxicidade  de  lidocaína  e  ropivacaína  e  da  combinac¸ão
de lidocaína  e  ropivacaína  foi  avaliada  em  linhagens  celulares  de  melanoma  humano.  Melfalano,
um agente  alquilante  de  mostarda  nitrogenada,  foi  usado  como  um  agente  de  controle  para  a
comparac¸ão da  atividade  citotóxica.
Métodos:  Linhagens  celulares  de  melanoma,  A375  e  Hs294T,  foram  expostas  por  1  hora
a concentrac¸ões  diferentes  dos  agentes  mencionados  acima.  A  viabilidade  celular  após  a
exposic¸ão foi  determinada  por  citometria  de  ﬂuxo.
Resultados:  Os  ALs  investigados  mostraram  citotoxicidade  prejudicial  nas  linhagens  celulares
de melanoma  estudadas  dependente  do  tempo  (p  <  0,001),  da  concentrac¸ão  (p  <  0,001)  e  do
agente. Em  ambas  as  linhagens  de  células  A375  e  Hs294T,  níveis  mínimos  de  viabilidade  celular
foram encontrados  após  72  horas  de  exposic¸ão  a  esses  agentes.  Lidocaína  a  2%  provocou  uma
reduc¸ão das  células  vitais  para  10%  ±  2%  e  14%  ±  2%  em  A375  e  Hs294T,  respectivamente,  após  72
horas de  exposic¸ão.  Ropivacaína  a  0,75%  após  72  horas  reduziu  as  células  viáveis  para  15%  ±  3%
e 25%  ±  3%,  em  A375  e  Hs294T,  respectivamente.  A  viabilidade  celular  mínima  após  exposic¸ão
de 72  horas  para  a  combinac¸ão  foi  de  10%  ±  2%  e  18%  ±  2%  em  A375  e  Hs294T,  respectivamente.
A viabilidade  celular  mínima  após  exposic¸ão  de  72  horas  ao  melfalano  foi  de  8%  ±  1%  e  12  ±  2,
em A375  e  Hs294T,  respectivamente.
Conclusão:  Os  ALs  possuem  atividade  citotóxica  em  linhagens  de  celulares  de  melanoma
humano de  modo  dependente  do  tempo,  da  concentrac¸ão  e  do  agente.  A  apoptose  nas  linhagens
celulares  foi  mediada  por  meio  da  atividade  das  caspases-3  e  caspases-8.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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A  little  is  known  about  chemotherapy  and  anesthetics  in
general.  In  perioperative  and  ambulatory  settings  local
anesthetics  are  administered  as  intra-articular  injections.1
Aminoamide  local  anesthetics  exhibit  their  activity  mainly
by  blocking  the  impulse  conduction  of  nerve  axons  in  a
reversible  manner.  Lidocaine  and  ropivacaine  both  belong
to  amino  amide  class  of  local  anesthetics  with  the  former
having  antiarrhythic  activity  (class-1b).  In  general,  local
anesthetics  (LAs)  prevent  or  relieve  pain  by  binding  to
speciﬁc  receptor  sites  on  the  sodium  (Na+)  channels  in
nerves  and  blocking  the  movement  of  ions  through  these
pores.  Both  the  chemical  and  pharmacologic  properties  of
individual  local  anesthetic  drugs  determine  their  clinical
properties.2 Local  anesthetics  including  lidocaine  applied
topically  have  been  shown  to  produce  good  pain  control  in
patients  with  oral  or  rectal  cancer.  Lidocaine  and  ropiva-
caine  are  used  at  a  concentration  of  1.5%  or  2.0%  and  0.5%
or  0.75%,  respectively,  for  surgical  anaesthesia  with  reduced
cardiotoxicty  and  CNS  toxicity.1,3,4 These  LAs  are  widely  used
for  pain  control  in  patients  with  head  and  neck  cancer,  to
inhibit  the  metastasis  and  relapse  of  tumours  and  to  reduce
surgical  stress  induced  inhibition  of  natural  killer  (NK)  cell
activity.  However,  both  in  vitro  and  in  vivo  studies  have
shown  cytotoxicity  towards  several  cultured  cells.5,6 Previ-
ous  publications  have  reported  that  single  dose  injection
s
c
uf  1%  lidocaine  may  have  signiﬁcant  chondrotoxic  activ-
ty.  Cytotoxicity  of  lidocaine  on  mesenchymal  stem  cells,
uman  oral  and  tumour  cells,  corneal  endothelial  cells  and
otor  cuff  tenoﬁbroblasts  has  been  reported  previously.7--13
opivacaine,  a  long-acting  aminoamide  local  anesthetic,
nhibits  inﬂux  of  sodium  ions  reversibly  and  thereby  blocks
mpulse  conduction  in  nerve  ﬁbres.  Ropivacaine  has  been
eported  to  demonstrate  reduced  potential  for  CNS  and  car-
iotoxicity  and  is  used  more  frequently  for  local  anesthesia
nd  in  the  management  of  labour  pain  and  postoperative
ain.  In  addition  to  local  anesthetic  activity,  ropivacaine
as  also  been  reported  to  inhibit  platelet  aggregation  and
ntibacterial  activity  in  in  vitro  studies.  Ropivacaine  was
lso  reported  to  be  cytotoxicity  on  mesenchymal  cell  lines
t  a  concentration  of  0.5%.  Neurotoxicity  of  local  anes-
hetics  was  associated  with  their  apoptosis.14--17,10,18 Despite
he  long  use  of  aminoamide  local  anesthetics  in  several
omplications,  there  is  inadequate  information  about  cyto-
oxic  activity  of  these  agents  and  this  need  to  be  studied
n  detail.  The  cytotoxic  activity  of  these  commonly  used
As  on  melanoma  has  not  yet  been  studied  extensively.
e  hypothesized  that  these  regularly  used  amino  amide
As  have  cytotoxic  effects  on  human  melanoma,  the  most
eadly  form  of  skin  cancer,  in  a  dose-,  time-,  and  agent-
peciﬁc  manner.  In  this  study,  besides  evaluating  different
oncentrations  of  the  above  stated  local  anesthetics  individ-
ally  we  have  also  investigated  the  combination  of  both  the
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ompounds  to  evaluate  cytotoxic  potential.  The  primary
urpose  of  the  study  was  to  investigate  whether  these  com-
only  used  LAs  have  cytotoxic  effects  on  the  melanoma
ell  lines.  In  this  study,  effect  of  pH  of  local  anesthetics
n  cell  death  of  melanoma  cell  lines  was  also  studied.  Cas-
ase  activity  test  was  performed  to  conﬁrm  whether  the  cell
eath  was  caused  by  apoptosis.  Melphalan,  a  nitrogen  mus-
ard  alkylating  agent,  is  a  chemotherapy  drug  that  acts  by
lkylating  DNA  nucleotide  guanine.  Melphalan  was  reported
o  be  cytotoxic  on  several  cell  lines  including  melanoma  and
herefore  is  used  as  a  standard  agent  to  evaluate  cytotoxic
otential  and  used  as  comparator.19,20
aterials and methods
aterials
idocaine,  ropivacaine,  and  melphalan  (137-58-6;  98717-
5-8  and  148-82-3,  respectively)  were  purchased  from
igma--Aldrich,  Germany.  All  these  drugs  and  reagents
ere  preservative  free  and  dissolved  in  buffered
aline  solution  (pH  7.0).  3-[4,5-Dimethylthiazol-2yl]-
,5-diphenyltetrazolium  bromide  (MTT)  was  purchased
rom  Sigma  Chem.  Ind.,  St.  Louis,  MO,  USA.
ell  culture
uman  malignant  melanoma  cell  line  A375  was  purchased
rom  Institute  of  Cell  Biology,  Shanghai  Institute  for  Bio-
ogical  Science,  Chinese  Academy  of  Science,  China.  The
ell  line  was  cultured  in  Dulbecco’s  Modiﬁed  Eagle’s  Medium
DMEM)  culture  medium  (Life  Technologies,  Carlsbad,  CA,
SA).  The  cell  line  was  supplemented  with  4  mM  glutamine,
he  dipeptide  l-alanyl-l-glutamine  that  prevents  degrada-
ion  and  ammonia  build  up  in  both  adherent  and  suspension
ultures,  and  5%  fetal  bovine  serum  (Life  Technologies).
s294T,  human  melanoma  cell  line  (Institute  of  Cell  Biology,
hanghai  Institute  for  Biological  Science,  Chinese  Academy
f  Science,  China)  was  cultured  in  DMEM  culture  medium
Lonza,  Basel,  Switzerland)  supplemented  with  2  mM  glu-
amine  (Life  Technologies)  and  5%  fetal  bovine  serum  (Life
echnologies).  The  normal  human  dermal  ﬁbroblast  (NHDF;
onza)  cell  line  was  cultured  in  MEM culture  medium
Lonza)  supplemented  with  2  mM  glutamine  (Life  Technolo-
ies)  and  10%  fetal  bovine  serum  (Life  Technologies).  Cells
ere  grown  to  conﬂuence  and  transferred  to  48  well  Plates
8  h  before  experimental  treatment.
All  the  media  contained  0.1  mg/mL  streptomycin,
00  U/mL  penicillin,  and  0.25  g/mL  amphotericin  B
Lonza).  The  cells  were  cultured  at  37 ◦C  in  a  humid  atmo-
phere  saturated  with  5%  CO2 at  95%  relative  humidity.
nalysis  of  cell  apoptosis  by  ﬂow  cytometry
idocaine  and  ropivacaine  form  the  group  of  aminoamide
ocal  anesthetics  but  differ  in  their  analgesic  potency,
nset  of  action  and  duration  of  anaesthesia.  Melanoma
ells  were  exposed  for  1  h  to  1  mL  of  local  anesthetics
olutions  with  following  concentrations:  0.03125%,  0.0625%,
.125%,  0.25%,  0.5%,  1.0%  and  2%  of  lidocaine,  and  0.03125%,
m
o
l
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.0625%,  0.125%,  0.25%,  0.5%,  and  0.75%  of  ropivacaine,
elphalan  (0.2%)  and  0.03125%,  0.0625%,  0.125%,  0.25%,
.5%,  and  0.75%  of  lidocaine  and  ropivacaine  combination.
he  concentration  of  test  compounds  ranged  from  0.03125%
o  2.0%.  Control  cells  were  treated  with  normal  saline  solu-
ion  for  1  h.  The  treated  solutions  containing  nonadherant
elanoma  cells  were  removed  and  centrifuged.  Formed
ell  pellets  were  washed  in  buffered  saline  and  returned
o  the  respective  wells  with  culture  medium.  After  24  and
2  h,  cell  viability  was  determined  using  ﬂow  cytometry.
o  determine  the  inﬂuence  of  pH  on  human  melanoma  cell
ines,  viability  rates  were  analysed  24  and  72  h  after  a  1-h
xposure  to  saline  solution  with  pH  of  7.4,  7.0,  6.0,  5.0,
nd  4.0.  Following  general  procedure  was  used  for  anal-
sis  of  melanoma  cell  viability:  A375  cells  (1  ×  106 mL−1)
ere  seeded  into  culture  plates  and  were  allowed  to  adhere
nd  harvested  after  treatment  with  lidocaine  ropivacaine
nd  combination  of  lidocaine  and  ropivacaine  for  24  h.
ontrols  included  unstained  cells  and  untreated  cells  (i.e.
ot  vehicle-treated).  All  processing  was  done  on  ice.  At
he  individual  time  points  culture  medium  was  collected,
ooled  with  the  suspended  cells  and  centrifuged  for  5  min  at
200  rpm  to  make  sure  that  all  the  cellular  material  was  col-
ected.  The  cell  pellets  were  suspended  in  500  L  1×  binding
uffer  at  a  density  of  approximately  1  ×  106 mL−1.  Samples
ere  incubated  with  1  L  Annexin  V-FITC  staining  and  5  L
I  for  exactly  5  min  at  room  temperature  in  the  dark  and
hen  samples  were  transferred  to  5  mL  FACS  tubes  and  then
easurement  was  carried  out  on  a  FACSCalibur  cytometer
Becton  Dickinson,  USA).  PI  and  V-FITC  ﬂuorescence  were
etected  in  the  FL-1  (green)  and  FL-2  (red)  channels,  respec-
ively,  after  correction  to  the  spectral  overlap  between  the
wo  channels.  CellQuest  software  (Becton  Dickinson,  Coun-
ry)  was  employed  to  analyse  the  data.1
ssay  for  caspase-3/8  activity
aspase-3/8  activity  was  analysed  at  12,  24  and  72  h  after
xposure  to  the  local  anesthetics  using  colorimetric  assay
its  (Keygen  Co.,  China).  Cells  (1  ×  106 well−1)  were  seeded
nto  6-well  plates,  and  treated  with  different  concentra-
ions  of  lidocaine,  ropivacaine  or  mixture  of  lidocaine  and
opivacaine  and  melphalan  for  12,  24  and  72  h.  Caspase-3
nd  caspase-8  hydrolyze  peptide  substrate  Ac-DEVD-PNA  and
c-IETD-PNA,  respectively,  which  leads  to  the  release  of  a
-nitroanilide  (pNA)  moiety.  pNA  concentration  calculated
ccording  to  the  absorbency  measured  at  a wavelength  of
05  nm  and  calibration  curve  based  on  standard  pNA  solu-
ions.  All  values  obtained  were  expressed  as  pNA/mg  of  total
rotein.  Further,  all  values  obtained  were  normalized  to  the
ell  viability  of  control.13
tatistical  analysis
ach  experiment  was  performed  in  triplicate  and  represen-
ative  data  were  reported.  One-way  ANOVA  was  employed  to
easure  mean  values  of  statistical  comparisons.  Correlation
f  the  variables  was  assessed  by  using  bivariate  corre-
ation  analysis.  Differences  with  p  <  0.05  were  considered
tatistically  signiﬁcant  and  all  p-values  were  determined  by
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Figure  1  Effect  of  ropivacaine  on  A375  melanoma  cell  viability.  A  dose--response  curve  of  cytotoxicity  of  ropivacaine  was  measured
(A) 24  h  and  (B)  72  h  after  a  1  h  exposure  using  ﬂow  cytometry.  (A  and  B)  Ropivacaine  concentrations  of  0.50%  and  0.75%  caused
ine  s
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Hsigniﬁcant decreases  in  cell  viability  compared  with  control  (sal
0.5%) after  24  and  72  h.  The  bars  represent  the  mean  values  of  
two-sided  tests.  The  statistical  analysis  was  performed  by
using  SPSS  12.0  software.
Results
Analysis  of  cell  viability  using  ﬂow  cytometryIn  this  study,  lidocaine,  ropivacaine  and  combination  of  lido-
caine  and  ropivacaine  demonstrated  a  concentration-,  time-
and  agent-dependant  cytotoxicity  to  human  melanoma  cells
(A375,  Hs294T)  and  the  results  obtained  were  comparable
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Figure  2  Effect  of  lidocaine  on  A375  melanoma  cell  viability.  Lid
decreases in  cell  viability  compared  with  control  (saline  solution)
(melphalan 0.5%)  after  24  and  72  h.  The  bars  represent  the  mean  val
#p  <  0.01;  control,  saline  solution;  standard,  melphalan  0.5%).olution)  and  were  comparable  with  standard  agent  (melphalan
riments  with  standard  error  as  error  bars  (*p  <  0.05; #p  <  0.01).
o  melphalan,  a  nitrogen  mustard  alkylating  agent,  used  as
 standard  agent  for  comparison  (Figs.  1--6).
Exposure  to  increasing  concentrations  of  lidocaine  and
opivacaine  resulted  in  a  decreasing  number  of  observable
iable  cells.  Treatment  with  a  combination  of  lidocaine
nd  ropivacaine  at  a  concentration  of  0.25%  and  higher
aused  a  signiﬁcant  decline  of  viable  cells  in  both  A375  and
s294T  cell  lines.  The  fraction  of  apoptotic  and  necrotic
ells  increased.  Minimum  viability  of  cells  was  observed  at  a
oncentration  of  0.75%  and  viability  rates  at  this  concen-
ration  were  15%  ±  2%  (p  <  0.005)  after  24  h  and  10%  ±  2%
p  <  0.005)  after  72  h,  respectively  (Fig.  3A  and  B).  In  A375
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Figure  3  Effect  of  combination  of  lidocaine  and  ropivacaine  on  A375  melanoma  cell  viability.  Viability  rates  were  signiﬁcantly
lowered by  combination  of  lidocaine  and  ropivacaine  concentrations  greater  than  0.25%  and  above  24  and  72  h  after  treatment.
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2  h,  respectively.
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 dose-dependent  manner  (Fig.  2A  and  B).  Lidocaine  at  a
l
o
l
120
A
100
80
60
40
20
0
Control 0.0325 0.0625 0.125 0.250
Concentration of ropivacaine, %
Ropivacaine
Ce
lls
 a
na
lyz
e
d 
(%
) -
 24
 ho
urs
0.500
#
0.750
#
Standard
#
igure  4  Effects  of  ropivacaine  on  Hs294T  melanoma  cell  viabil
easured 24  h  (A)  and  72  h  (B)  after  a  1-h  exposure  using  ﬂow  cyto
igniﬁcant decreases  in  cell  viability  compared  with  controls  (saline  
fter 24  and  96  h.  Viability  assessments  showed  no  relevant  differe
alues of  experiments  with  standard  error  as  error  bars  (*p  <  0.05; #prror  as  error  bars  (*p  <  0.05; #p  <  0.01;  control,  saline  solution;
oncentration  of  0.75%  and  higher  caused  reduction  of  the
ital  cells  in  A375  cell  line  and  minimum  viability  of  cells
ere  25%  ±  2%  (p  <  0.001)  and  10%  ±  2%  (p  <  0.005)  after  24
nd  72  h,  respectively.  Melphalan  was  used  as  a  standard
gent  and  it  caused  a  reduction  of  the  vital  cells  to  10%  ±  2%
p  <  0.001)  and  8%  ±  1%  (p  <  0.001)  after  24  and  72  h,  respec-
ively.Similar  results  were  obtained  in  Hs294T  melanoma  cell
ines,  further  conﬁrming  the  cytotoxic  effect  of  these  agents
n  melanoma  cell  lines  (Figs.  4--6).  In  this  study,  A375  cell
ine  was  more  sensitive  to  local  anesthetics  when  compared
120
B
100
80
60
40
20
0
Control 0.0325 0.0625 0.125 0.250
Concentration of ropivacaine, %
Ropivacaine
Ce
lls
 a
na
lyz
e
d 
(%
) -
 72
 ho
urs
0.500
#
0.750
*
Standard
#
ity.  A  dose--response  curve  of  cytotoxicity  of  ropivacaine  was
metry.  Ropivacaine  concentrations  of  0.50%  and  0.75%  caused
solution)  and  were  comparable  with  standard  (melphalan  0.5%)
nces  for  lower  concentrations.  The  bars  represent  the  mean
 <  0.01).
Cytotoxic  effects  of  local  anesthesia  through  lidocaine/ropivacaine  on  human  melanoma  cell  lines  599
120A
100
80
60
40
20
Control 0.0325 0.0625 0.125 0.250 0.500
Concentration of lidocaine, %
Lidocaine
Ce
lls
 a
na
lyz
e
d 
(%
) -
 24
 ho
urs
0.750
#
1.00
#
2.00
*
Standard
#
0
120B
100
80
60
40
20
Control 0.0325 0.0625 0.125 0.250 0.500
Concentration of lidocaine, %
Lidocaine
Ce
lls
 a
na
lyz
e
d 
(%
) -
 72
 ho
urs
0.750
#
1.00
#
2.00
#
Standard
#
0
Figure  5  Effects  of  lidocaine  on  Hs294T  melanoma  cell  viability.  Treatment  with  0.75%  and  higher  concentrations  of  lidocaine
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Figure  7  Effects  of  pH  on  melanoma  cell  viability.  Cell  lines  (A375  and  Hs294T)  were  not  affected  signiﬁcantly  after  a  1-h  exposure
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aspase-3/8  activity  analysis
poptosis  is  mediated  by  a  cascade  of  caspases  or  aspartate-
peciﬁc  cysteine  proteases.  Lidocaine,  ropivacaine,  and
he  combination  of  lidocaine  and  ropivacaine  signiﬁ-
antly  increased  the  expression  of  activated  caspase-3  and
aspase-8  in  a  time-dependent  manner  in  A375  cell  line
Fig.  8A  and  B).  Peak  levels  were  achieved  in  all  of  the
ocal  anesthetics  rapidly  after  12  h.  At  their  peaks,  all  these
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igure  8  Effect  of  ropivacaine  (0.75%),  lidocaine  (1.00%)  and  com
aspase-8 activities. and  7  days  using  ﬂow  cytometry.  The  ratios  of  vital  cells  are
 groups.  The  bars  represent  standard  error  as  error  bars.
gents  showed  signiﬁcant  higher  level  of  caspase  generation
ompared  with  the  control  group  (p  ≤  0.004).
iscussion
esults  from  the  conducted  study  supported  the  hypothe-
is  that  the  examined  aminoamide  local  anesthetics  posses’
ytotoxic  effect  on  human  melanoma  cell  lines.  Local
nesthetics  have  been  used  in  the  dermenhysis,  spinal
naesthesia,  and  topical  anesthesia  to  relieve  pain  in
atients  with  cancer.  Lidocaine  and  ropivacaine  are  clini-
ally  used  at  a  concentration  of  1.5%  or  2%  and  0.5%  or  0.75%,
espectively,  for  surgical  anesthesia.1,3 Ropivacaine  has  also
een  reported  to  be  less  cardio  toxic  and  less  central  ner-
ous  toxicity  than  lidocaine  and  other  commonly  used  local
nesthetics.  According  to  a  pharmacodyanmic  study  of  local
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RCytotoxic  effects  of  local  anesthesia  through  lidocaine/ropi
anesthetics,  ropivacaine  has  a  longer  action  time  and  higher
potency  when  compared  with  lidocaine.  Furthermore,  ropi-
vacaine  has  a  higher  recovery  rate  from  cardiac  arrest  than
lidocaine.21 However,  lidocaine  and  ropivacaine  have  been
reported  to  possess  cytotoxic  activity.22 Studies  have  also
been  reported  dose-  and  time-dependent  cytotoxic  effects
of  these  local  anesthetics  on  different  cancers.23--25 But,  not
much  research  has  been  performed  to  evaluate  the  effect  of
lidocaine  and  ropivacaine,  commonly  used  local  anesthetics,
on  human  melanoma  cell  lines  and  this  driven  the  authors
to  carry  out  the  present  study.  In  addition,  the  combination
study  of  two  local  anesthetics  was  also  carried  out  to  inves-
tigate  the  synergistic  cytotoxic  action  on  human  melanoma
cell  lines.  The  combination  of  same  class  of  local  anesthet-
ics,  i.e.  aminoamide,  was  devoid  of  any  compatible  issues
and  was  found  to  possess  synergistic  activity  and  the  cyto-
toxic  effect  from  the  combination  were  comparable  with
that  of  melphalan.  However,  in  the  present  study  ropiva-
caine  has  demonstrated  cytotoxic  activity  when  compared
with  normal  saline  solution  at  any  concentration,  but  was
less  cytotoxic  when  compared  with  lidocaine,  the  combina-
tion  and  melphalan.
Several  studies  have  shown  cytotoxic  effects  of  differ-
ent  concentrations  of  local  anesthetics  after  different  times
of  exposure  and  assessment.7--13 On  comparison  with  an
identical  experimental  setting  on  cancer  cell  lines,  human
melanoma  cell  lines  were  more  sensitive  to  local  anesthet-
ics  causing  more  cell  death  after  treatment  with  equal
concentrations  of  local  anesthetics  for  the  same  exposure
and  assessment  times.  After  exposure  to  local  anesthetics,
immediate  cell  death  might  have  been  caused  by  necrosis,
whereas  the  viability  of  cells  decreased  in  a  time-dependent
manner  over  several  hours.  Published  papers  reported  that
membrane  permeability  and  cytotoxicity  was  maximum
when  the  lipophilicity,  as  determined  by  the  octanol--water
partition  coefﬁcient  (log  p)  approached-3.26,27 This  ﬁnding
was  further  supported  by  our  work  in  which  ropivacaine
(log  p  =  2.91)  and  lidocaine  (log  p  =  2.56)  had  shown  cytotoxic
effects  on  A375  and  Hs294T  melanoma  cell  lines.  This  result
suggests  that  the  cytoxicity  of  local  anesthetics  is  very  much
related  to  their  membrane  permeability.
Acidity  of  the  local  anesthetics  could  be  one  of  the
causes  for  cytotoxic  effects  and  to  assess  the  same  the  cell
lines  were  treated  with  saline  solutions  with  a  pH  ranging
between  4.0  and  7.4.  Viability  assessment  showed  no  differ-
ences  across  the  studied  pH  range  and  cytotoxic  activity  due
to  acidity  of  local  anesthetics  can  be  excluded  in  this  study
(Fig.  7A  and  B).
Caspase  activity  was  evaluated  to  differentiate  whether
apoptosis  or  necrosis  was  responsible  for  cytotoxic  activity.13
Caspases  play  an  important  role  in  apoptosis  (programmed
cell  death),  necrosis  and  inﬂammation.  They  are  broadly
classiﬁed  by  their  roles  in  apoptosis  (caspase-3,  -6,  -7,  -8
and  -9  in  mammals)  and  in  inﬂammation  (caspases-1,  -4,  -5,
and  -12  in  humans).  Further,  caspases  involved  in  apoptosis
are  classiﬁed  based  on  mechanism  of  action  as  either  ini-
tiator  caspases  (caspases-8  and  -9)  or  executioner  caspases
(caspases-3,  -6,  and  -7).  In  the  apoptotic  cell,  caspases-3  is
activated  by  extrinsic  (death  ligand)  and  intrinsic  (mitochon-
drial)  pathways.28,29 In  this  study,  activity  of  both  caspases-3
and  caspases-8  was  increased,  suggesting  the  role  of  these
caspases  in  the  apoptosis  regulation  (Fig.  8A  and  B).ine  on  human  melanoma  cell  lines  601
In  this  study,  the  method  was  designed  to  decrease  and
o  approximately  measure  possible  iatrogenic  cell  dam-
ge  using  an  experimental  setting  in  monolayer  cultures.
ocal  anesthetics  exposure  can  impair  cellular  adherence
o  culture  discs.  So,  non-adherent  cells  in  the  study  were
ashed  and  returned  back.  Most  commonly  used  instru-
ent  to  measure  cell  viability  is  ﬂow  cytometry,  so  this  was
mployed  for  accurate  estimate  of  the  viability.4,25,30
Aminoamide  local  anesthetics  used  in  this  study  are
idely  used  to  treat  irritation,  soreness,  itchiness  and  are
njected  as  a  dental  anaesthetic,  or  used  as  local  anes-
hetics  for  minor  surgery.31,32 The  studied  local  anesthetics,
ncluding  combinations  of  lidocaine  and  ropivacaine,  were
ore  cytotoxic  at  higher  concentrations  than  at  lower  con-
entrations.  The  investigated  study  suggests  that  lidocaine,
opivacaine  and  combination  of  lidocaine  and  ropivacaine
an  be  further  investigated  for  their  anticancer  properties
or  the  treatment  of  melanoma  patients,  since  presently
vailable  chemotherapeutic  agents  possess  devastating  side
ffects.  The  combination  of  lidocaine  and  ropivacaine,  in
articular,  was  found  to  be  as  cytotoxic  as  that  of  melphalan,
 nitrogen  mustard  alkylating  agent  (10%  vs.  8%,  respec-
ively;  p  <  0.01).  The  studied  local  anesthetics  can  further
e  investigated  in  combination  with  other  anticancer  agents
r  with  other  local  anesthetics  for  synergistic  activity  on
elanoma  and  other  cancers.  On  the  other  hand,  authors
ased  on  the  results  of  this  study  recommend  using  commer-
ially  available  low  concentrations  of  the  less  cytotoxic  local
nesthetics,  such  as  bupivacaine  for  treatment  of  skin  and
elated  diseases  or  using  the  concentration  of  these  local
nesthetics  at  which  they  were  found  to  be  less  cytotoxic.
onclusion
he  cytotoxic  activity  of  the  investigated  aminoamide  local
nesthetics  on  melanoma  cell  lines  (A375  and  Hs294T)  is
ependent  on  concentration,  agent  and  exposure  time.  Of
he  studied  local  anesthetics,  ropivacaine  was  less  cyto-
oxic  when  compared  with  lidocaine  and  the  combination
f  lidocaine  and  ropivacaine.  Apoptosis  in  the  cell  lines  was
ediated  through  activity  of  caspases-3  and  caspases-8.  Cell
iability  was  not  affected  by  the  acidity  of  the  studied  local
nesthetics.  This  study  had  few  limitations.  In  this  study,
nly  two  cell  lines  were  investigated  and  this  is  an  in  vitro
tudy.  Although  the  study  gives  an  idea  of  cytotoxic  activity
f  these  agents  in  in  vitro  settings,  to  conﬁrm  this  activity
linical  trials  in  human  population  are  required.
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